Problem statement: Answer the MCQ question.
Query: Which compound exhibits a -9.402% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) O=C1C(Cc2c[nH]c3ccccc23)NC(=S)N1Cc1ccccc1
b) COc1cc(/C=C2\C(=O)ON=C2c2ccccc2)cc(OC)c1OC
c) CN(C1CCCCC1)S(=O)(=O)c1ccc(NC(=O)c2ccc(Br)o2)cc1
Answer: a. O=C1C(Cc2c[nH]c3ccccc23)NC(=S)N1Cc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1C(Cc2c[nH]c3ccccc23)NC(=S)N1Cc1ccccc1
O=C1C(Cc2c[nH]c3ccccc23)NC(=S)N1Cc1ccccc1
3-benzyl-5-(1H-indol-3-ylmethyl)-2-sulfanylideneimidazolidin-4-one